DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹8,629 Cr | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr |
What is the latest Net Current Assets ratio of DIVIS LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹8,629 Cr |
Mar2024 | ₹8,397 Cr |
Mar2023 | ₹8,211 Cr |
Mar2022 | ₹7,156 Cr |
Mar2021 | ₹5,062 Cr |
How is Net Current Assets of DIVIS LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹8,629 Cr | 2.76 | |
Mar2024 | ₹8,397 Cr | 2.27 | |
Mar2023 | ₹8,211 Cr | 14.74 | |
Mar2022 | ₹7,156 Cr | 41.36 | |
Mar2021 | ₹5,062 Cr | - |
Compare Net Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹160,691.2 Cr | 0.9% | -0.8% | 10.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,469.0 Cr | 0.5% | -2.3% | -12.5% | Stock Analytics | |
CIPLA | ₹125,034.0 Cr | -0.3% | -0.9% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,542.0 Cr | -3% | -2.4% | 3.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,571.0 Cr | 0.6% | 3.9% | -0.4% | Stock Analytics | |
MANKIND PHARMA | ₹106,634.0 Cr | -0.2% | 4.8% | 6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.9% |
-0.8% |
10.8% |
SENSEX | 1.2% |
1.9% |
-0.2% |
You may also like the below Video Courses